Opinion|Videos|May 1, 2024
Goals of Treatment for Patients With CLL
Josie Montegaard, MSN, AGPCNP-BC, discusses the goals of treatment for patients with chronic lymphocytic leukemia and how they may vary depending on factors such as age, risk level, and symptoms.
Advertisement
Episodes in this series
Advertisement
Related to this article
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Learn why hepatitis B can reactivate during cancer treatment, which therapies increase the risk and how antiviral medicines can help protect liver health.
After her sister’s Hodgkin lymphoma diagnosis, remission and relapse, a caregiver reflects on follow-up care, guilt and finding hope between cancer battles.
After a pancreatic cancer diagnosis upended his life and career, one survivor reflects on treatment, resilience and finding hope more than a decade later.
The American Society of Hematology published 2026 guidelines for adults with myelofibrosis on Oct. 14, 2026, with 10 recommendations on genetic testing, JAK inhibitors, anemia, transplant referral and aspirin.
Advertisement
Advertisement
Trending on CURE
1
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
4
Why Hepatitis B Matters During Cancer Treatment
5